Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

News

Nathan’s journey began in childhood. Just two months old when he was diagnosed with eczema, his symptoms were severe. “I don’t remember thinking about it as a problem when I was very young, I had no other expectations for how things should be,” he said. “But when I was five or six years old, and […]

Read More


What you need to know August 18, 2016 — Finding a treatment that works for your eczema or atopic dermatitis (AD) symptoms can feel like an endless cycle for some people. And it’s not just about finding the right medicine, but about getting it covered by your health plan as well. It’s hard enough when […]

Read More


By Debbie Byrnes August 18, 2016 — Itching for a Cure (IFAC). It’s a feel-good day surrounded by people who respect you for your perseverance. And it’s the only walk for eczema and helps raise money for research, support, and education. This year, IFAC will take place on Sunday, October 2, in Los Angeles. When […]

Read More


… I am a woman surviving it. July 19, 2016 — Who calls into work sick because of eczema? That’s what I’m sure people thought when I was consistently missing work due to lack of sleep, broken and bleeding skin, and sometimes just feeling too emotionally unstable to hold it together in the office. I […]

Read More


Understanding AD’s impact to improve your quality of life July 19, 2016 — People living with atopic dermatitis (AD), the most common and chronic form of eczema, know first-hand the burden AD has on both individuals and families. The impacts reach far beyond the serious effects of the disease symptoms such as itch, pain, and […]

Read More


Eczema affects more than 30 million people in the United States. The most common and chronic form of eczema is known as atopic dermatitis (AD). There is currently no cure for eczema or AD. To help raise awareness about the serious impact AD has on individuals and families, the National Eczema Association (NEA) has joined […]

Read More


We asked, you answered. The verdict? People living with eczema want more information and more options. This past January, many of you responded to a 6-question online survey to evaluate patient satisfaction and the role of doctors in the treatment of the most serious form of eczema, atopic dermatitis (AD). We learned that the vast majority of […]

Read More


Vice President, Advocacy and Access. Tim will be responsible for development and implementation of key advocacy initiatives that will advance NEA’s mission to improve the quality of life for individuals with eczema through research, support, and education. Tim most recently served as President of Foretop, a consulting firm that provided advocacy and business planning services […]

Read More


June 9, 2016 – On Monday, June 6, 2016 the pharmaceutical companies Regeneron and Sanofi, reported positive results for the Phase 3 the clinical trial of the new biologic drug, dupilumab, when used in conjunction with a topical corticosteroid by adults to treat moderate-to-severe atopic dermatitis (AD).

Read More


By Fatima Lakhani, BS and Peter A. Lio, MD Adapted, with permission, from original publication in Practical Dermatology. Introduction: Atopic dermatitis (AD) is a chronic itchy inflammatory disease that affects a large number of children and adults.1 The suffering is not limited to the skin; patients have increased rates of ADHD, depression, and anxiety.2 The […]

Read More